Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Announces Positive Results of Preclinical Study of Coca for Weight Gain Prevention
Jaguar Health announced that its joint venture, Magdalena Biosciences, reported positive preclinical results showing a coca leaf extract prevented weight gain in mice on a high-fat diet without reducing food intake. The extract is intended for post-GLP-1 weight loss management under FDA Botanical Guidance, addressing the unmet need of weight regain after stopping appetite-suppressing drugs.
Key figures
- Drug Name
- coca leaf extract
- Phase Of Trial
- preclinical
- Funding usd
- 1000000
- Study duration days
- 20
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.